Communications and Marketing

Cancer research in Germany joins forces

No. 07 | 04/02/2019 | by Koh

At the 1st German Cancer Research Congress, taking place on February 4 and 5 in Heidelberg, around 500 participants meet to exchange knowledge and ideas about what excellent research in Germany can contribute to the fight against the widespread disease of cancer. Anja Karliczek, Federal Minister of Education and Research, and Theresia Bauer, State Minister of Science, Research and the Arts, participated in the opening event on World Cancer Day.
The German Cancer Society (Deutsche Krebsgesellschaft), German Cancer Aid (Deutsche Krebshilfe) and the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) jointly organize the 1st German Cancer Research Congress (GCRC). It is the first joint initiative of the "National Decade Against Cancer" campaign.

The Chairmen of the first German Cancer Research Congress Frederik Wenz (German Cancer Society), Michael Baumann (German Cancer Research Center) and Gerd Nettekoven (German Cancer Aid) (left to right) with the Federal Minister of Education and Research Anja Karliczek.
© Uwe Anspach/ DKFZ

The Federal Minister of Education and Research, Anja Karliczek, said at the opening event: "In the National Decade Against Cancer, we intend to join forces. Researchers, physicians and all other partners unite in the battle to better comprehend cancer, prevent cancer and cure cancer. Our best tool is research. Therefore, the 1st German Cancer Research Congress is an ideal kickoff of the campaign. Here, the best brains in German cancer research come together with the goal of jointly taking on this disease."

Theresia Bauer, Baden-Wuerttemberg State Minister of Science, Research and the Arts, added: "In Germany, we have excellent cancer research at many locations. Heidelberg is one of the top international research locations. Nevertheless, more collaboration is needed if we want to achieve even more in cancer research. I am pleased that the top representatives of German cancer research are convening in Heidelberg to promote collaboration and exchange."

"With the GCRC, we offer Germany's first ever conference covering the entire spectrum of topics from basic cancer research through to the translation of research results into clinical trials," said DKFZ Chairman and Scientific Director Michael Baumann. "The event is intended to be a stimulus for closer cooperation within the cancer research community in Germany as part of the 'Decade Against Cancer' campaign."

"Reinforced cancer research is needed in order to further enhance the care of people who suffer from cancer and also to find more effective possibilities of preventing cancer for the whole population," said Gerd Nettekoven, Chairman of the Board of German Cancer Aid. He continued that particularly in the area of cancer risk factors, much evidence is still lacking and that prevention research in Germany must be given much higher priority than before. "For this reason, we are very pleased that prevention is part of the scientific program at the 1st German Cancer Research Congress and that it will also be at the top of the agenda in the 'National Decade Against Cancer'."

Tumor immunology is an example of research that directly concerns the patient: "In recent years, immunotherapies have virtually revolutionized the treatment of a number of cancer types," said Frederik Wenz, Member of the Council of the German Cancer Society. "However, alongside cases of sometimes spectacular curative outcomes, we also have many patients who do not benefit from the treatment. Why this is so and what can be done to change this are among the most pressing questions in cancer research." An equally topical question is which immunological therapy approaches will find their way into patient care besides the already established treatment with checkpoint inhibitors. Therefore, the congress dedicates a lecture session as well as a workshop to this topic.

In order to encourage communication and to emphasize the interactive character of the event, the organizers have placed a special focus on supporting formats such as an extensive poster exhibition. The discussion of research results initiates informal talks between scientists who share the same interests.

Numerous workshops are offered to promote an intensive exchange in small groups. They offer young scientists the possibility to enter into in-depth dialog with renowned scientists. The workshops focus particularly on topics relating to innovative technologies that have been introduced into cancer research very recently. Examples include the possibility to grow patient-individual tumor models (called organoids) in the Petri dish for testing agents in them as well as reprogramming cancer cells.

The large number of registrations confirms a great interest in the congress. Therefore, there are plans to offer this new congress format at regular two-year intervals in the future.

The congress is organized jointly by the DKFZ, the German Cancer Society (Deutsche Krebsgesellschaft), German Cancer Aid (Deutsche Krebshilfe) and their networks – the Network of Oncological Centers of Excellence (CCC network), the German Cancer Consortium (DKTK), the National Centers for Tumor Diseases (NCT), and the Experimental Cancer Research working group (AEK). The Federal Ministry of Education and Research (BMBF) provides financial support for the congress.

The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) with its more than 3,000 employees is the largest biomedical research institution in Germany. At DKFZ, more than 1,300 scientists investigate how cancer develops, identify cancer risk factors and endeavor to find new strategies to prevent people from getting cancer. They develop novel approaches to make tumor diagnosis more precise and treatment of cancer patients more successful. DKFZ’s Cancer Information Service (KID) provides individual answers to all questions about cancer for patients, the general public, and health care professionals. Jointly with partners from Heidelberg University Hospital, DKFZ runs the National Center for Tumor Diseases (NCT) located in Heidelberg and Dresden, and, also in Heidelberg, the Hopp Children’s Cancer Center (KiTZ). In the German Cancer Consortium (DKTK), one of six German Centers for Health Research, DKFZ maintains translational centers at seven university partnering sites. Combining excellent university hospitals with high-profile research at a Helmholtz Center at the NCT and DKTK sites is an important contribution to the endeavor of translating promising approaches from cancer research into the clinic in order to improve the chances of cancer patients. DKFZ is a member of the Helmholtz Association of National Research Centers, with ninety percent of its funding coming from the German Federal Ministry of Education and Research and the remaining ten percent from the State of Baden-Württemberg.


Subscribe to our RSS-Feed.

to top